Showing results (1-10 of 24) with videos related to

Sort By:
Pageof 3
Therapeutics and Clinical Risk Management|July 7, 2012
Assessment of malignancy risk in patients with multiple sclerosis treated with intramuscular interferon beta-1a: retrospective evaluation using a health insurance claims database and postmarketing surveillance dataGary Bloomgren, Bjørn Sperling, Kimberly Cushing, et al.
Neuroepidemiology|January 31, 2015
Relationship between sustained disability progression and functional system scores in relapsing-remitting multiple sclerosis: analysis of placebo data from four randomized clinical trialsThomas Scott, Ping Wang, Xiaojun You, et al.
The Annals of Thoracic Surgery|November 21, 2002
Neuron loss after coronary artery bypass detected by SPECT estimation of benzodiazepine receptorsLars S Rasmussen, Bjørn Sperling, Hanne H Abildstrøm, et al.
The Annals of Thoracic Surgery|May 9, 2002
Cerebral blood flow and cognitive dysfunction after coronary surgeryHanne Abildstrom, Peter Høgh, Bjørn Sperling, et al.
Expert Opinion on Drug Delivery|November 29, 2014
Multiple sclerosis patients treated with intramuscular IFN-β-1a autoinjector in a real-world setting: prospective evaluation of treatment persistence, adherence, quality of life and satisfactionRaymond Hupperts, Veit Becker, Janne Friedrich, et al.
British Journal of Clinical Pharmacology|April 11, 2016
COMPARE: Pharmacokinetic profiles of subcutaneous peginterferon beta-1a and subcutaneous interferon beta-1a over 2 weeks in healthy subjectsXiao Hu, Shulian Shang, Ivan Nestorov, et al.
The Journal of Headache and Pain|November 21, 2023
Long-term effectiveness of eptinezumab in patients with migraine and prior preventive treatment failures: extension of a randomized controlled trialMessoud Ashina, Stewart J Tepper, Astrid Gendolla, et al.
Neurology and Therapy|January 18, 2024
Eptinezumab Demonstrated Efficacy Regardless of Prior Preventive Migraine Treatment Failure Type: Post Hoc Analyses of the DELIVER StudyPatricia Pozo-Rosich, Messoud Ashina, Stewart J Tepper, et al.
The Journal of Headache and Pain|December 2, 2022
Effects of eptinezumab on self-reported work productivity in adults with migraine and prior preventive treatment failure in the randomized, double-blind, placebo-controlled DELIVER studyPiero Barbanti, Peter J Goadsby, Giorgio Lambru, et al.
European Journal of Neurology|December 30, 2022
Eptinezumab improved patient-reported outcomes and quality of life in patients with migraine and prior preventive treatment failuresPeter J Goadsby, Piero Barbanti, Giorgio Lambru, et al.
Pageof 3